Understanding patient expectations before treating Lyme disease symptoms
Official title: Impact of Patient's Pretreatment Expectations on Treatment Outcome of Early Lyme Borreliosis
Run by University Medical Centre Ljubljana · NCT03462329 · Data updated 2026-11-12
This study looks at how what patients expect from treatment affects their experience with symptoms after being treated for Lyme disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Medical Centre Ljubljana Academic / other |
| Locations | 1 site (Ljubljana) |
| Status | Recruiting |
| Started | June 1, 2018 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT03462329 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with erythema migrans due to early Lyme disease.
✕Probably not a fit
Patients who are pregnant, lactating, immunocompromised, or have recently taken antibiotics with antiborrelial activity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how patients' expectations about treatment outcomes influence their experiences with post-Lyme symptoms after being treated for early Lyme disease, specifically erythema migrans. Patients will complete a questionnaire to quantify their pretreatment expectations, which will then be correlated with their treatment outcomes. Additionally, the study will compare the prevalence of nonspecific symptoms in these patients to age-matched controls who do not have a history of Lyme disease.
Why it matters
Potential benefit: If successful, this study could help tailor treatment approaches based on patient expectations, potentially improving outcomes for those with Lyme disease.
How similar studies have gone: While this approach is relatively novel, similar studies have explored the impact of patient expectations on treatment outcomes in other conditions, showing promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * erythema migrans Exclusion Criteria: * pregnancy or lactation * immunocompromised * taking antibiotic with antiborrelial activity within 10 days
Where it's running
-
University Medical center Ljubljana
Ljubljana, Slovenia Recruiting
Study contacts
- Study coordinator: Daša Stupica
- Email: dasa.stupica@kclj.si
- Phone: +38615222110
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different amoxicillin treatments for erythema migrans
This study tests which length of amoxicillin treatment works best for people with erythema migrans, a common symptom of Lyme disease.
-
Lidocaine Infiltration to See If It Helps Inflammation and Brain Function After Head and Neck Cancer Surgery
This study tests whether different amounts of lidocaine injected into the surgical area can influence inflammation and brain-related outcomes after major head and neck cancer surgery in adults.
-
Minimal Sedation After Out-of-Hospital Cardiac Arrest
This study tests whether stopping continuous sedation right after return of circulation is as safe as keeping patients sedated in the early hours after OHCA.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Predicting pancreatogenic diabetes after partial pancreas removal
Aims to see if clinical, lab, imaging, and tissue findings before and after partial pancreas surgery can predict who will develop pancreatogenic diabetes.
-
Dexamethasone for tick-borne encephalitis
This trial will see if dexamethasone helps adults with confirmed tick-borne encephalitis who have meningitis, encephalitis, or meningomyelitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.